Genscript Biotech Corporation
1548
Rang în acțiuni
#2130
Operating as an investment holding company, Genscript Biotech Corporation,... Operating as an investment holding company, Genscript Biotech Corporation, established in 2002 and headquartered in Nanjing, People's Republic of China, specializes in the global provision of innovative life science research solutions, encompassing both products and services. Its market presence spans North America, Europe, China, Japan, other Asia Pacific regions, and numerous international markets. The enterprise structures its operations into four key divisions: The Life Science Services and Products segment delivers a wide array of research offerings, such as gene and oligonucleotide synthesis, molecular cloning, protein and peptide engineering, antibody production, molecular diagnostic instruments, and genomic editing materials. These resources are instrumental for fundamental biological investigations, pharmaceutical and drug discovery, disease diagnostics, vaccine development, and applications in agriculture, environmental science, and food production. The Biologics Development Services division supports pharmaceutical, biotechnology, governmental, and academic institutions. It provides comprehensive services for the full lifecycle of therapeutic antibodies, from initial discovery through pre-clinical and clinical development, alongside pre-clinical and clinical development for plasmids and viruses, and broader gene and cell therapy development. Dedicated to industrial applications, the Industrial Synthetic Biology Products segment engineers non-pathogenic microbial strains and manufactures specialized enzymes. These enzymes find utility across the food processing, animal feed, pharmaceutical, and chemical sectors. Finally, the Cell Therapy unit focuses on the pioneering discovery and advanced development of chimeric antigen receptor T-cell (CAR-T) therapies, specifically designed to combat both liquid and solid malignant tumors.
Preț acțiune
$4.19
Capitalizare de piață
$9.42B
Schimbare (1 zi)
-4.20%
Schimbare (1 an)
102.63%
Țară
HK
Tranzacționează Genscript Biotech Corporation (1548)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Genscript Biotech Corporation (1548)
Cel mai mare preț de închidere: $4.96 pe 2026-10-01
Cel mai mic preț de închidere: $0.17 pe 2015-12-01
Cel mai mic preț de închidere: $0.17 pe 2015-12-01
Istoric al prețului acțiunii pentru Genscript Biotech Corporation din 2015 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | 33.68% |
| 2025 | 31.10% |
| 2024 | -48.58% |
| 2023 | -9.14% |
| 2022 | -38.84% |
| 2021 | 203.18% |
| 2020 | -35.04% |
| 2019 | 59.03% |
| 2018 | -17.70% |
| 2017 | 306.93% |
| 2016 | 160.92% |
| 2015 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $535.81 | 25.65% |
US
|
|
| $188.41 | 601.69% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $890.95 | 9.43% |
NL
|
